Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in COVID 19 Vaccine

Pharma Giant Zydus Cadila Initiates Clinical Study On 1,048 Volunteers For Potential COVID-19 Vaccine

The participants should be able and willing to complete an informed consent process with an understanding of the purpose and procedures of the study

Read More

UL helps advance vaccination storage technologies with new World Health Organization accreditation

UL helps advance vaccination storage technologies with new World Health Organization accreditation

Read More

Moderna Spars With US Scientists Over COVID-19 Vaccine Trials

Moderna and other vaccine developers are working with the U.S. National Institutes of Health (NIH) and the Food and Drug Administration (FDA)

Read More

Emergent To Make Drug Substance For J&J's COVID-19 Vaccine Candidate

Johnson & Johnson had struck a deal with Emergent in April to use its manufacturing facilities and make more than 1 billion doses of a vaccine it is testing to stop the novel coronavirus.

Read More

Wall Street Shifts Bets To Big Pharma As COVID-19 Vaccine Race Progresses

Companies including Pfizer and Johnson & Johnson have said they each aim to produce as many as 1 billion doses by the end of 2021.

Read More

BioNTech And Pfizer's COVID-19 Vaccine Shows Potential In Human Trial

The potential treatment is the fourth early-stage COVID-19 drug to show promise in human testing, along with projects involving Moderna, CanSino Biologics and Inovio Pharmaceuticals.

Read More

Temasek-Led Investor Group In $250 Million Vaccine Bet On Biontech

The investors are in for an early reckoning because BioNTech has said it expects first clinical data on its COVID-19 vaccine development programme known as BNT162 this month or in July.

Read More

Pig Trial Of AstraZeneca's COVID-19 Vaccine Shows Promise With Two Shots

The researchers saw a marked increase in neutralising antibodies, which bind to the virus in a way that blocks infection," the Pirbright team said in a statement.

Read More

Sanofi Eyes Approval Of COVID-19 Vaccine By First Half Of 2021

Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021.

Read More

GSK In Quest To Be Best, Not First, In Race For COVID-19 Vaccine

GSK is one of more than 100 global players working on vaccines against COVID-19, which has killed about 350,000 people.

Read More

Volunteers put their lives at risk for COVID-19 vaccine

According to the US daily, large-scale trials of coronavirus vaccine candidates are scheduled to start this summer and fall with more conventional methods.

Read More

'Corona crisis will not last long, we'll get vaccine soon': Nitin Gadkari

'Corona crisis will not last long, we'll get vaccine soon': Nitin Gadkari

Read More

Indian Firm Panacea Says Aiming To Make COVID-19 Vaccine

Panacea's shares jumped 20% in morning trading on India's National Stock Exchange after the news.

Read More